These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36126478)

  • 1. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
    Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
    Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study.
    Njor SH; Søborg B; Tranberg M; Rebolj M
    Prev Med; 2023 Feb; 167():107405. PubMed ID: 36581010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in socioeconomic inequalities in cervical, breast, and colorectal cancer screening participation among women in Japan, 2010-2019.
    Ishii K; Tabuchi T; Iso H
    Cancer Epidemiol; 2023 Jun; 84():102353. PubMed ID: 36989957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent participation in screening for cervical, breast, and bowel cancer in England.
    Rebolj M; Parmar D; Maroni R; Blyuss O; Duffy SW
    J Med Screen; 2020 Mar; 27(1):9-17. PubMed ID: 31525303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attendance characteristics of the breast and colorectal cancer screening programmes in a highly urbanised region of the Netherlands: a retrospective observational study.
    Bongaerts THG; Büchner FL; de Munck L; Elferink MAG; Guicherit OR; Numans ME
    BMJ Open; 2023 Jun; 13(6):e071354. PubMed ID: 37355264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes†.
    Dawidowicz S; Le Breton J; Moscova L; Renard V; Bercier S; Brixi Z; Audureau E; Clerc P; Bastuji-Garin S; Ferrat E
    Fam Pract; 2020 Feb; 37(1):15-24. PubMed ID: 31305884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic factors affecting colorectal, breast and cervical cancer screening in an Asian urban low-income setting at baseline and post-intervention.
    Wee LE; Koh GC; Chin RT; Yeo WX; Seow B; Chua D
    Prev Med; 2012 Jul; 55(1):61-7. PubMed ID: 22561028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods to increase participation in organised screening programs: a systematic review.
    Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study.
    McCowan C; McSkimming P; Papworth R; Kotzur M; McConnachie A; Macdonald S; Wyke S; Crighton E; Campbell C; Weller D; Steele RJC; Robb KA
    Br J Cancer; 2019 Oct; 121(8):710-714. PubMed ID: 31481732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 12. Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.
    Vale DB; Anttila A; Ponti A; Senore C; Sankaranaryanan R; Ronco G; Segnan N; Tomatis M; Žakelj MP; Elfström KM; Lönnberg S; Dillner J; Basu P
    Eur J Cancer Prev; 2019 Mar; 28(2):131-140. PubMed ID: 29570103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
    Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
    Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Approach to population-based screening in the Czech Republic, methodology and first results of the personalised invitation of citizens to cancer screening programmes].
    Dušek L; Májek O; Bláha M; Daneš J; Zavoral M; Seifert B; Dvořák V; Skovajsová M; Suchánek S; Jung T; Brzková M; Klika P; Klimeš D; Koptíková J; Gregor J
    Klin Onkol; 2014; 27 Suppl 2():59-68. PubMed ID: 25494890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain.
    Lo SH; Waller J; Wardle J; von Wagner C
    J Med Screen; 2013 Jun; 20(2):73-9. PubMed ID: 23761420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "It's cancer screening after all". Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening.
    Kirkegaard P; Larsen MB; Andersen B
    J Med Screen; 2023 Jun; 30(2):74-80. PubMed ID: 36541340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation in breast cancer screening and its influence on other cancer screening invitations: study in women aged 56 years old in four French departments.
    Poiseuil M; Moutel G; Cosson M; Quertier MC; Duchange N; Darquy S
    Eur J Cancer Prev; 2023 May; 32(3):238-245. PubMed ID: 36779309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.